By proceeding, you agree to our Terms of Use and Privacy Policy.
IONETIX is a leading molecular imaging diagnostics and therapeutics company focused on providing physicians and patients access to N-13 Ammonia. Used by a growing number of academic institutions, N-13 Ammonia is rapidly changing the standard of excellence for myocardial perfusion in cardiac PET imaging. By combining our expertise, experience, and cutting-edge infrastructure solution, IONETIX creates new pathways for bringing N-13 Ammonia into your practice. Our innovative dose service model eliminates the up-front expense and provides the support needed to launch a successful cardiac PET program, while helping to establish a brand-differentiating service that keeps patients close and drives referrals. We invite you to explore our website for more information.
25-27 July 2023
The 2nd Annual Targeted Radiopharmaceuticals Summit US is set to take place, highlighting the industry's progress and growth as more compounds are moving through clinical trials. This event is the only industry-led meeting dedicated to accelerating T
Event Ended
USA
Paid
Boston